INFLUENCE OF COMBINED HYPOLYPIDEMIC THERAPY ON ACHIEVING TARGETED LDL LEVELS IN PATIENTS WITH IBS AND TYPE 2 DIABETES. Web teach. 2026, 4 (4), 112-114.